Zybio has more than 2,500 employees worldwide, of which R&D personnel and technical service personnel account for 1/3, master`s degree and above account for 42% . The company compared to spend no less than 15% of sales revenue on its research and development.

As a postdoctoral programme, Zybio is dedicated to attract more talents to focus on the cutting-edge technology in IVD field and take product research and development as the core driving force in the future’s continuous and rapid development. We have established several R&D centers distributed in China, like Chongqing R&D center, Beijing R&D center, Guangzhou R&D center, Shenzhen R&D center, Nanjing R&D center and Xiamen R&D center. The company’s main product covers clinical chemistry, immunoassay, molecular diagnosis, POCT, hematology, microbiology, pathological and other diagnostic products. It also has a comprehensive layout in core technical fields such as biological raw materials and chemical raw materials. Some products can also be applied to animal diagnosis.

Till now, we have obtained 279 product registration certificates and 38 invention patents. Zybio officially established a standardized reference measurement laboratory in 2018 and some key clinical chemistry items have passed the quality evaluation of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC-RELA).

Zybio has 66,000 m² manufacture plant, equipped with a modern qualified production workshop, and has 19 production lines including reagents and equipment. We have setup an international standard quality system and our products have passed ISO 90001 and ISO 13485. All products have passed strict quality inspection before shipping. The current production capacity can reach 2.0 billion kits of reagent and 20,000 equipment per year.

Zybio has became a leading enterprise in the field of medical equipment and one of the top 100 manufacturing enterprises in Chongqing.In order to provide comprehensive service for our customers, Zybio has developed broad marketing system worldwide. In China, we have established 79 service teams across 31 provinces, with the service ability of "1 hour response, 12 hours on-site ". Also, we have set up local marketing service system in overseas. Until now, our products have been sold to nearly 100 countries. Set up offices of overseas.

"Dedication To Accuracy", Zybio will continue to meet the various needs of customers, focus on innovation in IVD industry. We would cooperate deeply with global medical institutions to create greater value for customers and continuously strive for creating an international superb IVD brand!

Zybio EXM 3000, automatic nucleic acid extraction platform - Video